Related Experiment Videos
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study
D H Shevrin1, L J Kilton, T E Lad
1Evanston Hospital, Division of Medical Oncology, IL 60201, USA.
Investigational New Drugs
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Western Australian adolescent emotional wellbeing during the COVID-19 pandemic in 2020.
Child and adolescent psychiatry and mental health·2022
Inferring handedness from lithic evidence.
Laterality·2004
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
American journal of clinical oncology·2000
Assessment of coagulation system activation using spot urine measurements.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1999
A case of therapy-related extramedullary acute promyelocytic leukemia.
Cancer genetics and cytogenetics·1996
Parthenolide enhances imatinib activity in gastrointestinal stromal tumor models through stress-associated apoptosis.
Investigational new drugs·2026
First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
Investigational new drugs·2026
Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.
Investigational new drugs·2026